Stem Cell Reviews and Reports

, Volume 8, Issue 1, pp 91–99 | Cite as

The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good Practice

  • Alison Murdoch
  • Peter Braude
  • Aidan Courtney
  • Daniel Brison
  • Charles Hunt
  • James Lawford-Davies
  • Harry Moore
  • Glyn Stacey
  • Sebastian Sethe
  • for the Procurement Working Group of the National Clinical hESC Forum


The donation of human embryos for the derivation of embryonic stem cell lines that may be used in the development of therapeutic products raises more complex ethical, practical and regulatory problems than the donation of embryos for non-clinical research. This review considers these issues and offers recommendations for good practice.


Human embryonic stem cells Embryo research Embryo donation Regulation, Stem cell banks Cell therapy Stem cell therapy Donor screening Donor testing 


  1. 1.
    ISCBI. (2009). Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes; The international stem cell banking initiative. Stem Cell Review and Report, 5, 301–314.CrossRefGoogle Scholar
  2. 2.
    International Stem Cell Initiative, Adewumi O et al. (2007). Characterization of human embryonic stem cell lines by the International stem cell initiative. Nature Biotechnology, 25, 803–816.CrossRefGoogle Scholar
  3. 3.
    Haimes, E., & Taylor, K. (2009). Fresh embryo donation for human embryonic stem cell (hESC) research: The experiences and values of IVF couples asked to be embryo donors. Human Reproduction, 24(9), 2142–2150.PubMedCrossRefGoogle Scholar
  4. 4.
    McMahon, C., Gibson, F., Leslie, G., Saunders, D., Porter, K., & Tennant, C. (2003). Embryo donation for medical research: attitudes and concerns of potential donors. Human Reproduction, 18, 871–877.PubMedCrossRefGoogle Scholar
  5. 5.
    Laruelle, C., & Englert, Y. (1995). Psychological study of in vitro fertilization-embryo transfer participants’ attitudes toward the destiny of their supernumerary embryos. Fertility and Sterility, 63, 1047–1050.PubMedGoogle Scholar
  6. 6.
    Hoffman, D., Zellman, G., Fair, C., Mayer, J., Zeitz, J., Gibbons, W., et al. (2003). Cryopreserved embryos in the United States and their availability for research. Fertility and Sterility, 79, 1063–1069.PubMedCrossRefGoogle Scholar
  7. 7.
    Bjuresten, K., & Hovatta, O. (2003). Donation of embryos for stem cell research-how many couples consent? Human Reproduction, 18, 1353–1355.PubMedCrossRefGoogle Scholar
  8. 8.
  9. 9.
  10. 10.
  11. 11.
    Rabb, H.S. (1999). Federal funding for research involving human pluripotent stem cells. Memorandum to Harold Varmus. Memo, Archives, National Institutes of Health.Google Scholar
  12. 12.
    Thomson, J. A., Itskovitz-Eldor, J., Swiergiel, J., Shapiro, S., Waknitz, M. A., Marshall, S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 145–1147.CrossRefGoogle Scholar
  13. 13.
    Takahashi, K., Tanabe, K., Ohnuki, M., Megumi Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.PubMedCrossRefGoogle Scholar
  14. 14.
    ‘Position statement on regulating human embryonic stem cell lines for human application: joint statement from the Human Tissue Authority (HTA), Human Fertilisation and Embryology Authority (HFEA) and Medicines and Healthcare products Regulatory Agency (MHRA)’, originally issued 3 May 2007 and updated May 2008.Google Scholar
  15. 15.
    Veeck, L. (1999). An atlas of human gametes and conceptuses (pp. 47–50). New York: Parthenon.Google Scholar
  16. 16.
    Gardner, D. K., & Schoolcraft, W. B. (1999). In-vitro culture of human blastocysts. In R. Jansen & D. Mortimer (Eds.), Towards reproductive certainty: Fertility and genetics beyond (1999) (pp. 378–388). Carnforth: Parthenon.Google Scholar
  17. 17.
    Baxter Bendus, A. E., Mayer, J. F., Shipley, S. K., & Catherino, W. H. (2006). Interobserver and intraobserver variation in day 3 embryo grading. Fertility and Sterility, 86(6), 1608–1615.PubMedCrossRefGoogle Scholar
  18. 18.
    Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. (2011). The Istanbul consensus workshop on embryo assessment: Proceedings of an expert meeting. Human Reproduction, 26(6), 1270–1283.CrossRefGoogle Scholar
  19. 19.
    Filho, E. S., Noble, J. A., & Wells, D. (2010). A review on automatic analysis of human embryo microscope images. Open Biomedical Engineering Journal, 4, 170–177.PubMedCrossRefGoogle Scholar
  20. 20.
    Giorgetti, C., Terriou, P., Auquier, P., Hans, E., Spach, J., Salzmann, J., et al. (1995). Implantation: Embryo score to predict implantation after in-vitro fertilization: based on 957 single embryo transfers. Human Reproduction, 10(9), 2427–2431.PubMedGoogle Scholar
  21. 21.
    Gardner, D. K., Lane, M., & Schoolcraft, W. (2000). Culture and transfer of viable blastocysts: A feasible proposition for human IVF. Human Reproduction, 15(Suppl 6), 9–23.PubMedGoogle Scholar
  22. 22.
    Wong, C. C., Loewke, K. E., Bossert, N. L., Behr, B., De Jonge, C. J., Baer, T. M., et al. (2010). Non-invasive imaging of human embryos before embryonic genome predicts development to the blastocyst stage. Nature Biotechnology, 28(10), 1115–1121.PubMedCrossRefGoogle Scholar
  23. 23.
    Hewitt, Z. A., Amps, K. J., & Moore, H. D. (2007). Derivation of GMP raw materials for use in regenerative medicine: hESC-based therapies, progress toward clinical application. Development, 82(4), 448–452.Google Scholar
  24. 24.
  25. 25.
  26. 26.
    IUPAC glossary of terms used in toxicology, 2nd edition (IUPAC recommendations 2007); (2007) Pure Applied Chemistry, 79(7), 1153–1344.Google Scholar
  27. 27.
  28. 28.
    (2009). Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Review, 5, 301–314.Google Scholar
  29. 29.
    ENTR/C/8/SF D(2010) 380334 The rules governing medicinal products in the European union volume 4: EU guidelines for good manufacturing practice for medicinal products for human and veterinary use; Draft—Annex 2 manufacture of biological medicinal substances and products for human use.Google Scholar
  30. 30.
  31. 31.
  32. 32.
    Wingfield, M., & Cottell, E. (2010). Viral screening of couples undergoing partner donation in assisted reproduction with regard to EU Directives 2004/23/EC, 2006/17/EC and 2006/86/EC: What is the evidence for repeated screening? Human Reproduction, 25(12), 3058–3065.PubMedCrossRefGoogle Scholar
  33. 33.
  34. 34.
    Norris, S. J. (1982). In vitro cultivation of treponema pallidum: Independent confirmation. Infection and Immuntiy, 36(1), 437–439.Google Scholar
  35. 35.
    Guide to safety and quality assurance for the transplantation of organs, tissues and cells - 3rd edition & addendum (2009).

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Alison Murdoch
    • 1
  • Peter Braude
    • 2
  • Aidan Courtney
    • 4
  • Daniel Brison
    • 7
  • Charles Hunt
    • 3
  • James Lawford-Davies
    • 5
    • 6
  • Harry Moore
    • 8
  • Glyn Stacey
    • 3
  • Sebastian Sethe
    • 5
    • 6
  • for the Procurement Working Group of the National Clinical hESC Forum
  1. 1.Newcastle Fertility Centre at LifeNewcastle UniversityNewcastleUK
  2. 2.Division of Women’s HealthKing’s College LondonLondonUK
  3. 3.UK Stem Cell Bank, Division of Cell Biology and ImagingNational Institute for Biological Standards and ControlHertsUK
  4. 4.Roslin Cells LtdEdinburghUK
  5. 5.Newcastle UniversityNewcastleUK
  6. 6.Lawford Davies DenoonLondonUK
  7. 7.NorthWest Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Trust and the University of ManchesterManchester Academic Health Sciences CentreManchesterUK
  8. 8.Centre for Stem Cell BiologySheffield UniversitySheffieldUK

Personalised recommendations